Sort   by:  
 Page size 
UnknownSynthesis of Cis,syndiotactic A-alt-B Copolymers from Two Enantiomerically Pure Trans-2,3-Disubstituted-5,6-Norbornenes.
Not available
S-EPMC5043441 | biostudies-literature
UnknownImpact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer.
Not available
S-EPMC5903999 | biostudies-literature
UnknownCirculating Tumor DNA Enables Sensitive Detection of Actionable Gene Fusions and Rearrangements Across Cancer Types.
Not available
S-EPMC10870120 | biostudies-literature
UnknownThe Pan-Tumor Landscape of Targetable Kinase Fusions in Circulating Tumor DNA.
Not available
S-EPMC9377769 | biostudies-literature
UnknownHaploinsufficiency of ARID1B, a member of the SWI/SNF-a chromatin-remodeling complex, is a frequent cause of intellectual disability.
Not available
S-EPMC3309205 | biostudies-literature
UnknownROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non-Small Cell Lung Cancer.
Not available
S-EPMC5403618 | biostudies-literature
UnknownAnalytical validation of a homologous recombination deficiency signature (HRDsig) in pan-tumor tissue samples.
Not available
S-EPMC12622852 | biostudies-literature
UnknownTumor Fraction Correlates With Detection of Actionable Variants Across > 23,000 Circulating Tumor DNA Samples.
Not available
S-EPMC9616642 | biostudies-literature
UnknownRET rearrangements are actionable alterations in breast cancer.
Not available
S-EPMC6240119 | biostudies-literature
UnknownFirst-in-human trial of multikinase VEGF inhibitor regorafenib and anti-EGFR antibody cetuximab in advanced cancer patients.
Not available
S-EPMC5396533 | biostudies-literature
Sort   by:  
 Page size